-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pharm.
com News on July 16 A few days ago, Chia Tai Tianqing Pharmaceutical Group entered the administrative examination and approval stage with the generic 4 types of vothiaxetine hydrobromide tablets, which is expected to be approved and deemed to have been reviewed
.
According to data from Meinenet, in 2020, the total sales of vothiaxetine hydrobromide tablets in the terminals of Chinese public medical institutions and the terminals of Chinese urban physical pharmacies exceed 80 million yuan, and there is only one manufacturer in Lingbei
.
Among them, the growth rate of physical pharmacies in cities in China is the fastest, exceeding 200% in 2020
.
According to data, vothiaxetine hydrobromide tablets were developed by Lingbei.
It is an antidepressant drug mainly used for adult major depression.
It was approved for marketing in China in November 2017
.
Sales of vothiaxetine hydrobromide tablets at physical pharmacies in Chinese cities in recent years (unit: 10,000 yuan) Source: Mynet.
com China’s urban physical pharmacy terminal competition patterns.
According to data from Mynet, in 2020, it will be available in public hospitals and county-level public hospitals in China city community centers and township hospitals (referred to as the Chinese public medical institutions) terminal and city entities Chinese pharmacy terminal hydrobromide volts sulfur Paxil tablets total sales of over 80 million yuan, the production company only Lundbeck one
.
Among them, the growth rate of physical pharmacies in cities in China is the fastest, exceeding 200% in 2020
.
Source: One-click search on Meinenet.
Currently, there are 5 companies including Jiangsu Haosen Pharmaceutical Group, CSPC Ouyi Pharmaceutical, Chengdu Kanghong Pharmaceutical, etc.
that have submitted their listing applications under the new classification and are under review for vothiaxetine hydrobromide tablets.
Under review, after approval, it will be deemed as over-evaluated
.
Source: State Food and Drug Administration official website, Mi Nei.
com database Note: China's urban entity pharmacy terminal competition pattern database covers entity pharmacies in 293 prefectures and cities across the country (excluding county and rural entity pharmacies), and continuously monitors the entire category Enlarged version of the city's physical pharmacy database
.
The above sales are calculated based on the average retail price of the product at the terminal
.
com News on July 16 A few days ago, Chia Tai Tianqing Pharmaceutical Group entered the administrative examination and approval stage with the generic 4 types of vothiaxetine hydrobromide tablets, which is expected to be approved and deemed to have been reviewed
.
According to data from Meinenet, in 2020, the total sales of vothiaxetine hydrobromide tablets in the terminals of Chinese public medical institutions and the terminals of Chinese urban physical pharmacies exceed 80 million yuan, and there is only one manufacturer in Lingbei
.
Among them, the growth rate of physical pharmacies in cities in China is the fastest, exceeding 200% in 2020
.
According to data, vothiaxetine hydrobromide tablets were developed by Lingbei.
It is an antidepressant drug mainly used for adult major depression.
It was approved for marketing in China in November 2017
.
Sales of vothiaxetine hydrobromide tablets at physical pharmacies in Chinese cities in recent years (unit: 10,000 yuan) Source: Mynet.
com China’s urban physical pharmacy terminal competition patterns.
According to data from Mynet, in 2020, it will be available in public hospitals and county-level public hospitals in China city community centers and township hospitals (referred to as the Chinese public medical institutions) terminal and city entities Chinese pharmacy terminal hydrobromide volts sulfur Paxil tablets total sales of over 80 million yuan, the production company only Lundbeck one
.
Among them, the growth rate of physical pharmacies in cities in China is the fastest, exceeding 200% in 2020
.
Source: One-click search on Meinenet.
Currently, there are 5 companies including Jiangsu Haosen Pharmaceutical Group, CSPC Ouyi Pharmaceutical, Chengdu Kanghong Pharmaceutical, etc.
that have submitted their listing applications under the new classification and are under review for vothiaxetine hydrobromide tablets.
Under review, after approval, it will be deemed as over-evaluated
.
Source: State Food and Drug Administration official website, Mi Nei.
com database Note: China's urban entity pharmacy terminal competition pattern database covers entity pharmacies in 293 prefectures and cities across the country (excluding county and rural entity pharmacies), and continuously monitors the entire category Enlarged version of the city's physical pharmacy database
.
The above sales are calculated based on the average retail price of the product at the terminal
.